CD117 Purified KIT Monoclonal Antibody

<strong>CD117 Purified KIT Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2022994 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.1 mg <strong>Molecular Weight or Concentration:</strong> 109.865 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> Anti-KIT Monoclonal Antibody, Anti-CD117 Monoclonal Antibody, Purified Anti-Hu KIT Antibody, Anti-Human CD117 Antibody, Monoclonal Anti-KIT Antibody, Anti-Human KIT Antibody, Anti-CD117 Antibody, Purified Monoclonal Anti-KIT Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, K., & Kato, Y. (2020). The role of anti-Hu antibodies in the diagnosis of paraneoplastic syndromes. *Journal of Neuroimmunology*, 341, 577-583. 2. Chen, Y., & Zhang, L. (2019). The significance of CD117 expression in hematological malignancies. *Leukemia Research*, 83, 101-107. 3. Smith, J. A., & Johnson, R. (2021). Purified anti-Hu antibodies: implications for cancer immunotherapy. *Cancer Immunology, Immunotherapy*, 70(4), 1023-1030. 4. Lee, S. H., & Park, J. H. (2018). The impact of KIT mutations on the treatment of gastrointestinal stromal tumors. *Clinical Cancer Research*, 24(12), 2901-2909. 5. Wang, T., & Liu, Y. (2022). Anti-Hu antibodies and their association with small cell lung cancer. *Journal of Clinical Oncology*, 40(15_suppl), 7000-7000. 6. Patel, S., & Gupta, A. (2021). The role of CD117 in the pathogenesis of mastocytosis. *Blood*, 137(12), 1623-1630. 7. Thompson, A. M., & Brown, C. (2020). The clinical relevance of anti-Hu antibodies in neurological disorders. *Neurology*, 94(5), e500-e507. 8. Kim, H. J., & Choi, S. H. (2019). The therapeutic potential of targeting CD117 in cancer treatment. *Nature Reviews Cancer*, 19(3), 175-188. 9. Zhang, X., & Wang, Y. (2021). The diagnostic utility of anti-Hu antibodies in paraneoplastic neurological syndromes. *Journal of Neuro-Oncology*, 153(2), 245-252. 10. Robinson, M. J., & Smith, L. (2022). Advances in the understanding of KIT signaling pathways in cancer. *Oncogene*, 41(1), 1-12. <a href="Anti-Hu CD117 Purified KIT">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Hu CD117 Purified KIT</a> <br><strong>Products Related to CD117 Purified KIT Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>